Published in Oncology Business Week, March 29th, 2009
"Analysis was done on data from 33 patients after exclusion of 7 patients that had incomplete data. Pretreatment ADC value of complete responders (1.04 +/- 0.19 x 10(-3) mm(2)/s) was significantly lower (P < 0.05) than that from partial responders (1.35...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Oncology Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.